Sunesis Pharmaceutic (SNSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SNSS | AMGN | VRTX | REGN | BMY |
| Company | Sunesis Pharmaceutic | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 16.35 | 300.12 | 413.33 | 969.90 | 44.00 |
| High | 24.80 | 307.57 | 425.65 | 971.86 | 44.22 |
| Low | 16.35 | 298.89 | 412.12 | 952.14 | 43.56 |
| Last | 18.62 | 307.31 | 418.82 | 955.76 | 43.67 |
| Change | +3.64 | +7.01 | +8.58 | -14.21 | -0.37 |
| % Change | +24.30% | +2.33% | +2.09% | -1.46% | -0.84% |
| Volume | 20,069,086 | 2,859,047 | 1,651,186 | 424,923 | 11,927,103 |
| 20-Day Average Volume | 6,608,405 | 2,869,677 | 1,133,759 | 524,216 | 14,406,535 |
| Previous Close | 14.98 | 300.30 | 410.24 | 969.97 | 44.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.35 | 277.32 | 399.69 | 913.16 | 46.39 |
| 20-Day Raw Stochastic | 62.71% | 75.31% | 80.28% | 83.34% | 4.65% |
| 20-Day Relative Strength | 78.29% | 65.94% | 59.98% | 57.22% | 28.89% |
| Weighted Alpha | +200.53 | +32.33 | +21.35 | +28.13 | -36.84 |
| Today's Opinion | 88% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 88% Buy | 40% Buy | 32% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 40% Buy | 8% Sell | 24% Buy | 40% Buy | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +35.37% since 02/17/21 | +10.79% since 05/01/24 | +4.15% since 05/01/24 | +5.79% since 05/01/24 | -1.22% since 05/01/24 |
| Low | 3.53 on 02/22/21 | 274.90 on 05/02/24 | 394.03 on 05/07/24 | 891.30 on 05/02/24 | 43.33 on 05/02/24 |
| High | 7.09 on 02/24/21 | 322.60 on 05/03/24 | 425.65 on 05/08/24 | 971.86 on 05/08/24 | 44.62 on 05/06/24 |
| 1-Month | |||||
| %Chg | +75.58% since 01/22/21 | +14.16% since 04/08/24 | +3.61% since 04/08/24 | +1.84% since 04/08/24 | -14.54% since 04/08/24 |
| Low | 2.35 on 01/28/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 7.09 on 02/24/21 | 322.60 on 05/03/24 | 425.65 on 05/08/24 | 971.86 on 05/08/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +291.18% since 11/24/20 | +4.23% since 02/08/24 | -1.00% since 02/08/24 | +0.99% since 02/08/24 | -10.35% since 02/08/24 |
| Low | 1.33 on 11/25/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 7.09 on 02/24/21 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +92.27% since 08/24/20 | +12.46% since 11/08/23 | +11.10% since 11/08/23 | +16.16% since 11/08/23 | -16.69% since 11/08/23 |
| Low | 1.12 on 11/06/20 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 7.09 on 02/24/21 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 96,255 | 161,091,424 | 106,030,224 | 106,465,840 | 89,273,480 |
| Shares Outstanding, K | 18,093 | 536,435 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 2,070,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -23,330,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | N/A | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 2.21 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 03/09/21 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.08 | 26.73 | 25.83 | 41.81 |